Histopathological regression after neoadjuvant docetaxel, oxaliplatin, fluorouracil, and leucovorin versus epirubicin, cisplatin, and fluorouracil or capecitabine in patients with resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4-AIO): results from the phase 2 part of a multicentre, open-label, randomised phase 2/3 trial
Al-Batran, Salah-Eddin, Prof, Hofheinz, Ralf D, Prof, Pauligk, Claudia, PhD, Kopp, Hans-Georg, MD, Haag, Georg Martin, MD, Luley, Kim Barbara, MD, Meiler, Johannes, MD, Homann, Nils, Prof, Lorenzen, Sylvie, MD, Schmalenberg, Harald, MD, Probst, Stephan, MD, Koenigsmann, Michael, Prof, Egger, Matthias, MD, Prasnikar, Nicole, MD, Caca, Karel, Prof, Trojan, Jörg, Prof, Martens, Uwe M, Prof, Block, Andreas, MD, Fischbach, Wolfgang, Prof, Mahlberg, Rolf, MD, Clemens, Michael, Prof, Illerhaus, Gerald, Prof, Zirlik, Katja, MD, Behringer, Dirk M, Prof, Schmiegel, Wolff, Prof, Pohl, Michael, MD, Heike, Michael, Prof, Ronellenfitsch, Ulrich, MD, Schuler, Martin, Prof, Bechstein, Wolf O, Prof, Königsrainer, Alfred, Prof, Gaiser, Timo, Prof, Schirmacher, Peter, Prof, Hozaeel, Wael, MD, Reichart, Alexander, MD, Goetze, Thorsten O, MD, Sievert, Mark, MD, Jäger, Elke, Prof, Mönig, Stefan, Prof, Tannapfel, Andrea, Prof
Published in The lancet oncology (01.12.2016)
Published in The lancet oncology (01.12.2016)
Get full text
Journal Article
Perioperative chemotherapy with fluorouracil plus leucovorin, oxaliplatin, and docetaxel versus fluorouracil or capecitabine plus cisplatin and epirubicin for locally advanced, resectable gastric or gastro-oesophageal junction adenocarcinoma (FLOT4): a randomised, phase 2/3 trial
Al-Batran, Salah-Eddin, Homann, Nils, Pauligk, Claudia, Goetze, Thorsten O, Meiler, Johannes, Kasper, Stefan, Kopp, Hans-Georg, Mayer, Frank, Haag, Georg Martin, Luley, Kim, Lindig, Udo, Schmiegel, Wolff, Pohl, Michael, Stoehlmacher, Jan, Folprecht, Gunnar, Probst, Stephan, Prasnikar, Nicole, Fischbach, Wolfgang, Mahlberg, Rolf, Trojan, Jörg, Koenigsmann, Michael, Martens, Uwe M, Thuss-Patience, Peter, Egger, Matthias, Block, Andreas, Heinemann, Volker, Illerhaus, Gerald, Moehler, Markus, Schenk, Michael, Kullmann, Frank, Behringer, Dirk M, Heike, Michael, Pink, Daniel, Teschendorf, Christian, Löhr, Carmen, Bernhard, Helga, Schuch, Gunter, Rethwisch, Volker, von Weikersthal, Ludwig Fischer, Hartmann, Jörg T, Kneba, Michael, Daum, Severin, Schulmann, Karsten, Weniger, Jörg, Belle, Sebastian, Gaiser, Timo, Oduncu, Fuat S, Güntner, Martina, Hozaeel, Wael, Reichart, Alexander, Jäger, Elke, Kraus, Thomas, Mönig, Stefan, Bechstein, Wolf O, Schuler, Martin, Schmalenberg, Harald, Hofheinz, Ralf D
Published in The Lancet (British edition) (11.05.2019)
Published in The Lancet (British edition) (11.05.2019)
Get full text
Journal Article
Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer: The Randomized Multicenter Phase II NEPAFOX Trial
Goetze, Thorsten O., Reichart, Alexander, Bankstahl, Ulli S., Pauligk, Claudia, Loose, Maria, Kraus, Thomas W., Elshafei, Moustafa, Bechstein, Wolf O., Trojan, Jörg, Behrend, Matthias, Homann, Nils, Venerito, Marino, Bohle, Wolfram, Varvenne, Michael, Bolling, Claus, Behringer, Dirk M., Kratz-Albers, Karsten, Siegler, Gabriele M., Hozaeel, Wael, Al-Batran, Salah-Eddin
Published in Annals of surgical oncology (01.06.2024)
Published in Annals of surgical oncology (01.06.2024)
Get full text
Journal Article
ASO Visual Abstract: Adjuvant Gemcitabine Versus Neoadjuvant/Adjuvant FOLFIRINOX in Resectable Pancreatic Cancer—The Randomized Multicenter Phase II NEPAFOX Trial
Goetze, Thorsten O., Reichart, Alexander, Bankstahl, Ulli S., Pauligk, Claudia, Loose, Maria, Kraus, Thomas W., Elshafei, Moustafa, Bechstein, Wolf O., Trojan, Jörg, Behrend, Matthias, Homann, Nils, Venerito, Marino, Bohle, Wolfram, Varvenne, Michael, Bolling, Claus, Behringer, Dirk M., Kratz-Albers, Karsten, Siegler, Gabriele M., Hozaeel, Wael, Al-Batran, Salah-Eddin
Published in Annals of surgical oncology (01.06.2024)
Published in Annals of surgical oncology (01.06.2024)
Get full text
Journal Article
Randomized multicenter phase II/III study with adjuvant gemcitabine versus neoadjuvant/adjuvant FOLFIRINOX in resectable pancreatic cancer: The NEPAFOX trial
Al-Batran, Salah-Eddin, Reichart, Alexander, Bankstahl, Ulli Simone, Pauligk, Claudia, Kraus, Thomas Werner, Bechstein, Wolf Otto, Trojan, Jorg, Behrend, Matthias, Potenberg, Jochem, Homann, Nils, Venerito, Marino, Bohle, Wolfram, Varvenne, Michael, Bolling, Claus, Behringer, Dirk M., Kratz-Alber, Karsten, Siegler, Gabriele Margareta, Hozaeel, Wael, Goetze, Thorsten Oliver
Published in Journal of clinical oncology (20.01.2021)
Published in Journal of clinical oncology (20.01.2021)
Get full text
Journal Article
Randomized multicenter phase II/III study with adjuvant gemcitabine versus neoadjuvant/adjuvant FOLFIRINOX in resectable pancreatic cancer: The NEPAFOX trial
Hozaeel, Wael, Pauligk, Claudia, Homann, Nils, Luley, Kim, Kraus, Thomas Werner, Trojan, Jorg, Bechstein, Wolf O., Grimm, Kersten, Heise, Bettina, Schmiegel, Wolff, Pink, Daniel, Al-Batran, Salah-Eddin
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
IMAB362 plus zoledronic acid (ZA) and interleukin-2 (IL-2) in patients (pts) with advanced gastroesophageal cancer (GEC): Clinical activity and safety data from the PILOT phase I trial
Sahin, Ugur, Al-Batran, Salah-Eddin, Hozaeel, Wael, Zvirbule, Zanete, Freiberg-Richter, Jens, Lordick, Florian, Just, Marianne, Bitzer, Michael, Thuss-Patience, Peter C., Krilova, Anna, Brass, Volker, Mueller, Christian, Daalman, Elmar, Tureci, Oezlem
Published in Journal of clinical oncology (20.05.2015)
Published in Journal of clinical oncology (20.05.2015)
Get full text
Journal Article
The impact of docetaxel-related toxicities on health-related quality of life in patients with metastatic cancer (The QoLiTax-Trial of the Arbeitsgemeinschaft Internistische Onkologie, AIO)
Pauligk, Claudia, Hozaeel, Wael, Hofheinz, Ralf, Hinke, Axel, Windemuth-Kieselbach, Christiane, Tauchert, Felix Karl, Hübner, Andreas, Burmester, Martin, Koenigsmann, Michael, Wiegand, Jörg, Eggert, Jochen, Welslau, Manfred, Kuhl, Rosemarie, Al-Batran, Salah-Eddin
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Interim analysis of a phase I/II open label, dose-escalating study to investigate safety, tolerability, and preliminary efficacy of the trifunctional anti-HER2/neu x anti-CD3 antibody ertumaxomab in patients with HER2/neu expressing solid tumors progressing after standard therapy
Haense, Nicole, Pauligk, Claudia, Marme, Frederik, Werner, Dominique, Sorgius, Daniela, Hozaeel, Wael, Rafiyan, Mohammad-Reza, Ottmann, Oliver G., Klunker, Daniel, Jäger, Michael, Jäger, Elke, Lindhofer, Horst, Al-Batran, Salah-Eddin
Published in Journal of clinical oncology (20.05.2014)
Published in Journal of clinical oncology (20.05.2014)
Get full text
Journal Article
Interim safety results from a phase II/III trial with 5-FU, oxaliplatin, and docetaxel (FLOT) versus epirubicin, cisplatin, and 5-FU (ECF) in patients with locally advanced, resectable gastric/oesophagogastric junction (OGJ) cancer: A study of the AIO
Koock, Ulrike, Pauligk, Claudia, Luley, Kim Barbara, Mayer, Frank, Schulmann, Karsten, Homann, Nils, Schmalenberg, Harald, Hozaeel, Wael, Hofheinz, Ralf, Probst, Stephan, Mahlberg, Rolf, Koenigsmann, Michael, Haag, Georg Martin, Meiler, Johannes, Prasnikar, Nicole, Behringer, Dirk M., Trojan, Jorg, Egger, Matthias, Jäger, Elke, Al-Batran, Salah-Eddin
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article
A prospective trial for defining a subset of patients with limited metastatic gastric cancer who may be candidates for bimodal treatment strategies: FLOT3
Al-Batran, Salah-Eddin, Hofheinz, Ralf, Homann, Nils, Illerhaus, Gerald, Martens, Uwe Marc, Stoehlmacher-Williams, Jan, Schmalenberg, Harald, Luley, Kim Barbara, Prasnikar, Nicole, Egger, Matthias, Probst, Stephan, Hartmann, Joerg Thomas, Moehler, Markus Hermann, Arnold, Dirk, Fischbach, Wolfgang, Pauligk, Claudia, Hozaeel, Wael, Moenig, Stefan Paul, Hölscher, Arnulf H, Jäger, Elke
Published in Journal of clinical oncology (20.05.2012)
Published in Journal of clinical oncology (20.05.2012)
Get full text
Journal Article